
Breast cancer organoids as alternative to animal models
Breast cancer remains the most frequently diagnosed malignancy in women worldwide and a leading cause of
Breast cancer remains the most frequently diagnosed malignancy in women worldwide and a leading cause of
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue
What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a
As the global obesity crisis intensifies, the functional aspect of brown adipose vs white adipose tissue
Modern drug discovery is shifting from “one-size-fits-all” animal models toward new-approach methodologies (NAMs) that capture human-specific
About this white paper Animal testing has played a crucial role in medical advancements, leading to
SCIENTIFIC POSTER — Adipose tissue organoid model from stromal vascular fraction Mathilde Cadoux, PhD; Emilie Ouanounou;
Abstract Integration of reconstructed human skin (RhS) into organ-on-chip (OoC) platforms addresses current limitations imposed by
Spheroids, as a good universal organ model ? Recent advances in bioengineering of cells, tissue coupled
14 rue de la Beaune,
93100 Montreuil (Paris)
France
+33 9 87 04 70 35
contact@cherrybiotech.com
All right reserved to © Cherry Biotech 2023